PTBP2

polypyrimidine tract binding protein 2, the group of Heterogeneous nuclear ribonucleoproteins|RNA binding motif containing

Basic information

Region (hg38): 1:96721665-96823738

Links

ENSG00000117569NCBI:58155OMIM:608449HGNC:17662Uniprot:Q9UKA9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PTBP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTBP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
missense
9
clinvar
9
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 0 9 1 2

Variants in PTBP2

This is a list of pathogenic ClinVar variants found in the PTBP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-96721870-C-A not specified Uncertain significance (Jul 11, 2023)2610421
1-96749651-A-T not specified Likely benign (Oct 27, 2020)1301613
1-96751419-T-C Benign (Oct 10, 2018)786466
1-96751477-A-C not specified Uncertain significance (Jun 06, 2023)2557884
1-96769734-A-G Benign (Jun 20, 2018)713770
1-96769750-G-T not specified Uncertain significance (Dec 01, 2022)2387292
1-96770784-G-A not specified Uncertain significance (Nov 08, 2022)2324820
1-96770795-A-G not specified Uncertain significance (Oct 06, 2021)2253498
1-96777630-A-G not specified Uncertain significance (May 10, 2022)2288382
1-96785115-C-T Benign (Aug 02, 2017)720990
1-96785224-G-A not specified Uncertain significance (Aug 02, 2021)2240386
1-96804812-C-G not specified Uncertain significance (May 14, 2024)3311085
1-96804872-G-A not specified Uncertain significance (Jun 02, 2023)2556125
1-96806905-A-G not specified Uncertain significance (Jun 11, 2024)3311087
1-96812716-G-A not specified Uncertain significance (Sep 22, 2021)2249202
1-96812927-C-G not specified Uncertain significance (Jun 17, 2024)3311084
1-96813340-C-G not specified Uncertain significance (May 30, 2024)3311086

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PTBP2protein_codingprotein_codingENST00000426398 14102074
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9990.00117125186021251880.00000799
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.201342870.4680.00001453481
Missense in Polyphen32121.230.263951499
Synonymous0.1729799.20.9780.000005051053
Loss of Function4.59228.40.07040.00000168314

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.00005450.0000544
Finnish0.000.00
European (Non-Finnish)0.000008870.00000882
Middle Eastern0.00005450.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: RNA-binding protein which binds to intronic polypyrimidine tracts and mediates negative regulation of exons splicing. May antagonize in a tissue-specific manner the ability of NOVA1 to activate exon selection. In addition to its function in pre-mRNA splicing, plays also a role in the regulation of translation. Isoform 5 has a reduced affinity for RNA. {ECO:0000269|PubMed:11003644, ECO:0000269|PubMed:12667457}.;
Pathway
TarBasePathway;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;mRNA Processing;internal ribosome entry pathway (Consensus)

Recessive Scores

pRec
0.124

Intolerance Scores

loftool
0.290
rvis_EVS
-0.52
rvis_percentile_EVS
21.2

Haploinsufficiency Scores

pHI
0.848
hipred
Y
hipred_score
0.816
ghis
0.666

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.696

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ptbp2
Phenotype
growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);

Gene ontology

Biological process
mRNA splice site selection;spinal cord development;cerebellum development;negative regulation of RNA splicing;regulation of neural precursor cell proliferation
Cellular component
spliceosomal complex;growth cone;neuronal cell body
Molecular function
RNA binding;mRNA binding